Pfizer CEO calls on industry to increase R&D efficiency

07/28/2008 | Bloomberg

Drugmakers need to boost "efficiencies in research and development" to bolster innovation, Pfizer CEO Jeff Kindler told Bloomberg Television. Kindler's decision to divide Pfizer's R&D operation into smaller therapeutic units helped replenish its pipeline, which may have as many as 28 treatments in late-stage development by the end of 2009.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX